|
Jan 18
|
Why Catalyst Pharmaceutical (CPRX) is a Top Momentum Stock for the Long-Term
|
|
Jan 15
|
3 Biotech Stocks You Can Buy and Hold for the Next Decade
|
|
Jan 14
|
Forget Shiba Inu: This Stock is Poised for a Potential Bull Run in 2024
|
|
Jan 12
|
Why Catalyst Pharmaceutical (CPRX) is a Top Growth Stock for the Long-Term
|
|
Jan 9
|
If You Invested $1000 in Catalyst Pharmaceutical a Decade Ago, This is How Much It'd Be Worth Now
|
|
Jan 9
|
Catalyst (CPRX) is an Incredible Growth Stock: 3 Reasons Why
|
|
Jan 9
|
Catalyst Pharmaceuticals, Inc. Announces Closing of Public Offering
|
|
Jan 5
|
Catalyst Pharmaceuticals, Inc. Announces Pricing of Public Offering of Common Stock
|
|
Jan 4
|
Catalyst Pharmaceuticals, Inc. Announces Proposed Public Offering of Common Stock
|
|
Jan 3
|
How to Boost Your Portfolio with Top Medical Stocks Set to Beat Earnings
|
|
Dec 18
|
Catalyst Pharmaceuticals Announces FIRDAPSE® New Drug Application Submitted in Japan by Partner DyDo Pharma
|
|
Dec 8
|
Why Is Catalyst (CPRX) Up 16.2% Since Last Earnings Report?
|
|
Dec 5
|
Catalyst Pharmaceuticals Receives Prestigious Ranking on Forbes 2024 List of America's Most Successful Small-Cap Companies
|
|
Dec 4
|
Catalyst Pharmaceuticals Announces Appointment of Michael W. Kalb as Chief Financial Officer and Other Executive Promotions
|
|
Nov 8
|
Catalyst Pharmaceuticals Reports Strong Third Quarter 2023 Financial Results and Corporate Update
|
|
Nov 2
|
Catalyst Pharmaceuticals Receives Two New U.S. Patent Allowances For FIRDAPSE®
|
|
Nov 2
|
Amylyx Pharmaceuticals, Inc. (AMLX) Earnings Expected to Grow: What to Know Ahead of Q3 Release
|
|
Nov 1
|
Catalyst Pharmaceutical (CPRX) Reports Next Week: Wall Street Expects Earnings Growth
|
|
Sep 27
|
If EPS Growth Is Important To You, Catalyst Pharmaceuticals (NASDAQ:CPRX) Presents An Opportunity
|
|
Sep 8
|
Why Is Catalyst (CPRX) Down 14% Since Last Earnings Report?
|